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As β-lactams are reconsidered for the treatment of tuberculosis (TB), their targets are
assumed to be peptidoglycan transpeptidases, as verified by adduct formation and
kinetic inhibition of Mycobacterium tuberculosis (Mtb) transpeptidases by carbapenems
active against replicating Mtb. Here, we investigated the targets of recently described
cephalosporins that are selectively active against non-replicating (NR) Mtb. NR-active
cephalosporins failed to inhibit recombinant Mtb transpeptidases. Accordingly, we used
alkyne analogs of NR-active cephalosporins to pull down potential targets through
unbiased activity-based protein profiling and identified over 30 protein binders. None
was a transpeptidase. Several of the target candidates are plausibly related to Mtb’s
survival in an NR state. However, biochemical tests and studies of loss of function
mutants did not identify a unique target that accounts for the bactericidal activity of
these beta-lactams against NR Mtb. Instead, NR-active cephalosporins appear to kill
Mtb by collective action on multiple targets. These results highlight the ability of these
β-lactams to target diverse classes of proteins.
Keywords: M. tuberculosis, cephalosporin, non-replicating, β-lactams, ABPP, click chemistry
INTRODUCTION
The chemotherapy of tuberculosis (TB) remains challenging, with an urgent need for shorter,
safer treatment whose effectiveness extends to TB resistant to current regimens (Murray et al.,
2016). Cure of a high proportion of patients with drug-sensitive TB depends on use of multiple
antibiotics for at least 6 months. In part, this is thought to reflect the phenotypic antimicrobial
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resistance that is characteristic of non-replicating (NR) bacterial
populations (Nathan, 2012). To this end, several strategies have
been proposed to improve the treatment course against NR
bacteria (Murray et al., 2016; Gold and Nathan, 2017). One
strategy involved a search for drugs that can kill Mtb in vitrowhen
it has been made NR by conditions that mimic those found in
the host (Bryk et al., 2008; Mak et al., 2012; Grant et al., 2013;
Gold and Nathan, 2017).
The bacterial cell wall is the target of many antibiotics,
β-lactams among them. However, the cell wall of mycobacteria
was considered refractory to inhibition by β-lactams for
decades following the demonstration that penicillin was inactive
against Mtb (Abraham et al., 1941). β-Lactams are the most
highly prescribed antibiotics in modern medicine (Bush and
Macielag, 2010) and have utility in diverse infections (Wivagg
et al., 2014). Mtb’s resistance to β-lactams was attributed
to the natural resistance of its peptidoglycan transpeptidases,
the robust production of a class A β-lactamase (BlaC), and
the limited permeability of its thick, waxy outer cell wall.
Peptidoglycan peptide crosslinking in mycobacteria relies largely
but not completely on L,D-transpeptidases (Ldts) that catalyze
transpeptidation via an active site cysteine rather than the
serine of D,D-transpeptidases (Mainardi et al., 2005). D, D-
transpeptidases along with D,D-carboxypeptidases and D,D-
endopeptidases are the classical targets of β-lactams and are
collectively called penicillin binding proteins (PBPs). In Mtb,
as much as 80% of peptidoglycan crosslinks are mediated
by Ldts (Lavollay et al., 2008) when cells are in stationary
phase compared to 30–40% of the crosslinks in replicating cells
(Wietzerbin et al., 1974).
Over the years, interest in β-lactams for the treatment
of TB has undergone a renaissance, spurred in part by the
discovery that the carbapenem, meropenem, combined with
the β-lactamase inhibitor clavulanic acid, sterilized replicating
cultures of Mtb within 2 weeks of incubation (Hugonnet et al.,
2009), along with the demonstration of the vulnerability of Ldts
to β-lactam inhibition. A long-term case study of 18 patients
with extensively drug-resistant TB concluded that including
meropenem/clavulanate in the treatment regimen was beneficial
to outcomes (Payen et al., 2018). While various carbapenems,
including faropenem, are the most effective β-lactams at
inhibiting Mtb Ldts (Kumar et al., 2017), cephalosporins also
bind the Ldts of Mtb (Dubee et al., 2012b; Kumar et al.,
2017) and Enterococcus faecium (Dubee et al., 2012a). Also, a
previous study observed that the activity of rifampicin, a first-
line antimycobacterial, is enhanced when co-administered with
several cephalosporins in vitro (Ramón-García et al., 2016). The
underlying basis of this synergy remains unknown.
We recently screened a β-lactam library against Mtb under
both replicating and NR conditions that mimic the host
environment, the latter set of conditions consisted of hypoxia,
low pH, a flux of nitric oxide generated from nitrite, and
butyrate as a carbon source (Gold et al., 2015b). We found
two cephalosporins, compounds 1 and 5, that were exclusively
active against NR Mtb and were cidal to Mtb in mouse bone
marrow-derived macrophages (Gold et al., 2016b). Restriction
of activity to NR Mtb raised the question whether these
cephalosporins might have non-canonical targets (Baranowski
and Rubin, 2016) beyond transpeptidation enzymes.
Further suggesting the likelihood of non-canonical targets,
the NR-active cephalosporins bear an ester or an oxadiazole
(an ester isostere) at the C2′ position of the cephalosporin
core, rather than the free carboxylic acid characteristic of
inhibitory cephalosporins (Chauvette and Flynn, 1966; Jen
et al., 1972). The importance of the free carboxylic acid
is highlighted in the crystal structure of the acyl-enzyme
tetrahedral intermediate between PBP2x from Streptococcus
pneumoniae and cefuroxime, which showed tight hydrogen
bonding between Thr550 in the active site and the carboxylic
acid of cefuroxime (Gordon et al., 2000). Loss of this interaction
with Thr550 reduced affinity for 2nd- and 3rd-generation
cephalosporins and increased resistance to cephalosporins
in clinical isolates (Mouz et al., 1999). Furthermore, the
crystal structures of the Mtb LdtMt1 (Correale et al., 2013)
and LdtMt2 (Bianchet et al., 2017) showed tight hydrogen
bonding interactions between three active site side chains
and the carboxylate of several carbapenems bound to the
active site cysteine.
Alternative targets of β-lactams, with no obvious relationship
to enzymes involved in peptidoglycan metabolism, have been
reported in other organisms. A monobactam inhibited the
Escherichia coli signal peptidase SPase (Kuo et al., 1994).
Crystallization of E. coli SPase with a β-lactam was achieved
using a penem with an ester at the carboxylate position
(Paetzel et al., 1998). Certain cephalosporins esterified at
the C2′′ carboxylate inhibit human leukocyte elastase (HLE)
(Doherty et al., 1986).
In the NR state, peptidoglycan biosynthesis is anticipated to
slow or completely arrest as the bacilli halt replication. Ldts,
obvious candidate targets of β-lactams, play an essential role
for replicating Mtb and their role in maintaining peptidoglycan
synthesis in NR Mtb is not as well understood. Thus, we first
tested if NR-active cephalosporins inhibited recombinant Mtb
Ldts. To explore the possibility of non-canonical targets, we then
turned to activity-based protein profiling (ABPP) to seek other
potential target(s).
ABPP has been adopted to find binding partners for
ligands that target cysteine, serine, and metallohydrolases,
ATP-binding proteins, phosphatases, and other enzyme
classes (Cravatt et al., 2008). ABPP makes use of alkyne or
azide analogs of the ligand of interest, which can then be
conjugated via a Cu(I)-mediated azide alkyne cycloaddition
reaction to create a handle for enrichment and purification
or labeling (Speers and Cravatt, 2009), followed by peptide
mass fingerprinting to identify binding proteins. In Mtb, ABPP
has been used to elucidate the serine hydrolase landscape of
replicating and hypoxic NR cells (Ortega et al., 2016) and
to identify a protein that binds agrimophol, a cidal natural
product that disrupts Mtb’s intrabacterial pH homeostasis
(Zhao et al., 2015).
In this study, by using ABPP, we identified candidate target
proteins for NR-active cephalosporins that belonged to diverse
protein families. Conspicuously absent were Ldts and PBP
transpeptidases and carboxypeptidases.
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RESULTS
NR-Active Cephalosporins Do Not Inhibit
Mtb Ldts and Are Not Susceptible to
BlaC Cleavage
Given the importance of Ldts in Mtb’s adaptation to stress
conditions, we first queried if there was any notable interaction
between Mtb Ldts and compounds 1, 5, and the carboxylic acid
analog, 9c (Figure 1A). LdtMt1 and LdtMt2 were selected for
their critical role in mycobacterial biology (Schoonmaker et al.,
2014). No inhibitory activity was detected (Figure 1B) with
or without prior incubation with the compounds. The molar
extinction coefficient (1ε) of the hydrolyzed compounds was
determined by incubating 1, 5, and 9c with Klebsiella pneumoniae
carbapenemase, KPC-2. Partial hydrolysis of 1 and 5 was
achieved after 1,000 min while 9c was rapidly hydrolyzed. Neither
compound 1 nor 5 could be hydrolyzed by the Ldts. Furthermore,
stopped-flow kinetics were performed using E. faecium. Ldtfm
failed to detect an interaction with 1 or 5. Considering that 9c
interacted with LdtMt1, LdtMt2, and Ldtfm as expected, it seemed
likely that the lack of a charged carboxylate alters the binding of
the compounds and, most likely, 1 and 5 do not have canonical
cephalosporin targets. Next, we tested the susceptibility of the
three compounds to hydrolysis by Mtb BlaC. Mtb BlaC was
unable to hydrolyze 1 or 5; however, as with KPC-2, 9c was readily
degraded with a turnover rate of 40 min−1 (Figure 1B). Neither 1
nor 5 inhibited BlaC hydrolysis of nitrocefin, even after a 2-h pre-
incubation. These findings led us to opt for an unbiased approach
to finding potential targets of 1 and 5.
Chemo-Proteomic Approach to Target
Identification
We synthesized alkyne analogs of 1 and 5 that retained
NR activity comparable to that of the parent compounds
(Figures 1A,C). The alkyne tag was coupled to either the C2′
carboxyl (C) or C7′ amino (N) group of each cephalosporin,
yielding compounds C1a, N1, C5, and N5. All four tagged
compounds retained NR activity and none gained activity
against replicating Mtb (replicating MIC90 ≥ 100 µM; data
not shown). Thus, we were able to apply the probe compounds
to intact, live NR Mtb rather than having to treat lysates
prepared from NR Mtb. Achieving reproducible and compound-
specific labeling of both membrane-associated and cytoplasmic
proteins required overcoming several technical challenges. In our
preliminary experiments, we found that use of a biotin azide
or a desbiotin azide linker led to problems with the elution of
non-specific proteins bound to the agarose-streptavidin resin and
the contamination of samples with streptavidin, which could
FIGURE 1 | Activity and design of alkyne probes for ABPP. (A) Structures and non-replicating (NR) MICs of compounds 1, 5, and 9c. (B) Percent inhibition of
nitrocefin hydrolysis and compound hydrolytic activity of LdtMt1, LdtMt2, and BlaC when incubated with compounds 1, 5, and 9c. (C) Structure and NR MICs of
alkyne derivatives. (D) Structure of the biotin-diol linker used for purification and identification of proteins bound to the cephalosporin probes.
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mask target proteins of low abundance. We remedied this with
a biotin linker containing a 1,2-diol near the azide (Figure 1D)
that allowed periodate-mediated oxidative cleavage of the linker.
We used a high biomass of Mtb to increase the likelihood of
capturing low abundance protein(s). This required setting up
experiments using a high bacterial inoculum and adjusting the
compound concentrations to account for the inoculum effect
observed in 1, 5, and many other β-lactams (Gold et al., 2016b),
in which the compounds became less potent as the starting
inoculum was raised from 0.01 OD580 to 0.1. Not only did the
antimycobacterial activity of the alkynes mirror the activity of the
parent compounds in standard MIC and charcoal agar resazurin
assays (CARA) (Figures 1C, 2A) where the OD580 is adjusted
to 0.01, but they remained cidal despite the high inoculum of
5 × 108 CFU/ml (an approximate OD580 of 1.0) after 7 days
of incubation (Figure 2B). Similar to the parent compounds
(Gold et al., 2016b), activity of their alkyne analogs was largely
dependent on the inclusion of nitrite in the NR conditions
(Figure 2C). The standard MIC of the alkyne analogs and the
parent compounds was comparable to that of oxyphenbutazone
(OPB, Supplementary Table S1), which is active in the non-
replicating 4-stress model (Gold et al., 2012).
The methods used to label, enrich, purify, and elute bound
target proteins are shown schematically in Figure 3. C1a, which
contained the alkyne handle at the C2′ carboxylic acid group,
labeled the proteome more robustly than the N1 probe, which
carried the alkyne at C7′ amino moiety (Figure 4A). The same
pattern was observed between C5 and N5 probes (Figure 4B),
suggesting preferential orientation of these cephalosporins with
binding partners to which they could most readily undergo the
azide alkyne cycloaddition reaction and subsequent detection.
Boiling the beads after the oxidation reaction did not release
any additional biotinylated proteins (Figure 4B), suggesting that
the periodate chemical cleavage was complete. Furthermore,
no proteins were detected in the flow-through (Figure 4C),
which indicated that binding of the tagged proteins to the
streptavidin-agarose was comprehensive. Having removed the
biotin tag, we visualized the proteins in the concentrated eluates
by silver staining the SDS-PAGE gels (Figure 4D).
C5 and C1a Binding Proteins Are Not
Involved in Peptidoglycan Synthesis
After optimizing assay conditions and purification steps
(Figure 3), we conducted ABPP on two independent experiments
using C1a, C5, and a vehicle control (1% DMSO). No probe-
specific proteins were identified with the N1 or N5 probes
and, therefore, analytical efforts were focused on results with
C1a and C5. The C5 probe pulled down a much smaller set of
protein binders (39 proteins) than the C1a probe (426 proteins)
(Table 1). The majority were not detected in the vehicle-treated
control cells. Of the proteins identified using C5, 93% were
also identified using C1a. In order to assess the specificity of
binding, ABPP with C1a was conducted in the presence of 1
or 5 as competitors. Recovery of 185 of the 205 reproducible
candidate binders was reduced by at least 100-fold when C1a
was co-incubated with 1 and unaffected by co-incubation with 5
(Table 1 and Supplementary Table S2). The set of 185 proteins
included 28 of the 30 proteins that were pulled down with C5.
Thus, the 30 proteins identified with C5 were considered to be
the most reproducible and specifically targeted by the NR-active
cephalosporins. These were chosen for further study.
Genetic and Biochemical Studies of
Non-essential Binding Protein
The proteins isolated with the C5 probe belonged to several
protein families, 16 of which are essential under replicating
conditions (Table 2). Notably, known targets of β-lactams were
not among them. Given that the compounds are specifically cidal
to NR Mtb, we initially reasoned that these essential proteins
may not be the targets whose inhibition would account for
cidality only under NR conditions. Several of the proteins are
predicted or have been verified to be involved in the following
functions: fatty acid biosynthesis: DesA2, DesA1, HtdY, and
FIGURE 2 | Activity of alkyne analogs against Mtb at a high inoculum. (A) Activity of compound 1 and alkyne derivatives against NR Mtb in standard NR conditions
at an initial OD580 of 0.1. (B) Cidality of alkyne analogs in the non-replicating pull-down assay conditions that included a 24-h pre-exposure to NR conditions and a
high inoculum (OD580 of 1.0). Cells were exposed to alkyne analogs for 24 h or 7 days. After 7 days of exposure, C1a, N1, and C5 significantly reduced viability
(***p < 0.005). (C) Activity of alkyne analogs after 7 days under NR conditions without the flux of nitric oxide, *p = 0.045.
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FIGURE 3 | The ABPP strategy used for labeling potential protein binders to C1a, N1, C1, and N5. (A) The strategy involved 24-h exposure of NR pre-conditioned
Mtb cells to test compounds, lysis, and solubilization of cellular and membrane proteins in Triton X-114. (B) Conjugation of the probe–protein complex to the
diol-biotin linker via a Cu(I)-catalyzed Huisgen’s azide-alkyne cycloaddition reaction. (C) Streptavidin purification followed by periodate/diol linker cleavage. (D) Mass
spectrometry analysis of eluents and removal of non-specific protein binders.
AcpM; β-oxidation: EchA1, FadD31, and Rv3224; ribosome
function: Tsf, Tuf, RplJ, and Rv1738; universal stress proteins:
Rv2005, Rv2623, and Rv1996 (Table 2). Of the proteins with
non-essential roles under replicating conditions, 13 of the 14
NR-cephalosporin-binding proteins that are not essential under
replicating conditions (DeJesus et al., 2017) were assessed for
their potential essentiality under NR conditions.
We focused first on shortlisted proteins (Table 2) that are
unannotated: Rv0250, Rv1738, and Rv0786. Of these, only Rv1738
has a published crystal structure (Bunker et al., 2015). The dimer
of Rv1738 bears a striking similarity to the structure of E. coli’s
hibernation promoting factor, which plays a role in imposing
an NR state. Accordingly, we purified recombinant Rv1738
protein (Supplementary Figure S1), which eluted in dimeric
form (Figure 5A). When incubated with purified Mtb ribosomes,
Rv1738 inhibited up to 80% of translation of luciferase mRNA in
a concentration-dependent manner. Thus, Rv1738 appears to be
an Mtb ortholog of hibernation factor. However, the addition of
1, 5, or C5 did not alter this interaction (Figure 5B).
Rv0786 is an uncharacterized conserved protein. Although
the percent sequence identity was below 25%, 66% of Rv0786’s
structure was predicted with 100% confidence by Phyre2 3D
software (Kelley et al., 2015) to share similarities with class
B3 metallo-β-lactamases (Supplementary Figure S2A). Rv0786
contained the metal binding site common to Class 3 β-lactamases
such as FEZ-1 and AIM-1 (Supplementary Figure S2B) (Sun
et al., 2018). To test the role of Rv0786 in the survival of the
bacteria under NR conditions, a transposon mutant of rv0786
from a predicted loss-of-function library was prepared in the
Hung laboratory at the Broad Institute. The rv0786 mutant
showed neither decreased survival nor a change in response to
5 compared to the WT strain (Supplementary Figures S2C,D).
Loss-of-function transposon mutants from the Hung
library for the following binding partners showed no change
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FIGURE 4 | Biotin labeling, streptavidin purification, and elution of proteins bound to NR-active cephalosporins. (A) The labeling of lysate proteins with click
chemistry reaction was visualized by Western blot using Alexa Fluor streptavidin conjugate (Thermo Fisher Scientific, United States). The soluble fraction (SF) or
precipitated (PP) protein samples treated for 24 h with DMSO (DM), C1a, or N1. (B) Western blot of the PP fraction following streptavidin purification of samples
treated with DMSO, C1a, C5, or N5; precipitate (PP), periodate elution (E), boiled bead elution (B), streptavidin flow through (FT). Directly underneath is a loading
control protein gel stained with Coomassie. (C) Western blot of PP fraction binding to streptavidin beads of samples treated with DMSO, C1a; N1; C5; precipitate
(PP), streptavidin flow through (FT). (D) Silver staining of periodate elution (E) and C1a precipitate for comparison.
in the survival of the bacteria to the NR assay conditions.
The mutants that we tested included those disrupted in
the genes encoding the universal stress proteins Rv1996,
TABLE 1 | Selection criterion and total number of final proteins identified.
Parent compound 1 5
Alkyne derivative (bait) C1a C5
Bacterial proteins with >2 unique peptides 426 39
Not found in DMSO 97% 82%
Competed with parent compound 45% Not determined
Reproducible binders 48% 77%
% of total number of
proteins ID’d
Precipitate fraction
Bacterial proteins with >2 unique peptides 413 29
Not found in DMSO 406 24
Reproducible binders 197 22
Soluble Fraction
Bacterial proteins with >2 unique peptides 13 10
Not found in DMSO 8 8
Numbers used to tabulate pull down totals and are bolded for emphasis.
Rv2005c, and Rv2326c (Supplementary Figures S2C,D, and
data not shown), known or potential fatty acid metabolism
enzymes Rv3224 (possible short chain dehydrogenase),
Rv0222 (EchA1), and Rv3389 (putative HtdY) (Figure 6A
and Supplementary Figures S3A,B), LldD (possible L-
lactate dehydrogenase), and PdxH, pyridoxine 5′-oxidase
(Supplementary Figures S3A,B).
The 4-stress NR model provides butyrate as the carbon
source. Because there is a high degree of redundancy among
enzymes involved in β-oxidation (Williams et al., 2011), we
explored the pathway as a whole by altering the carbon
source in the NR model. The carbon source markedly affected
the susceptibility of Mtb to the NR-active cephalosporins
(Figures 6B,C). Compared to standard NR conditions, in which
the carbon source was butyrate, NR conditions lacking any
carbon source reduced the susceptibility of Mtb both to the
NR-active cephalosporins and to rifampicin (Supplementary
Figure S4B). Compared to the control in which no carbon
source was added, butyrate, propionate, and, to a lesser
extent, hexanoate increased Mtb’s susceptibility to 5. In
contrast, acetate increased Mtb’s resistance to 5 and 1
without altering susceptibility to rifampicin (Figure 6C)
compared to the no-carbon control. The non-fatty acid
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carbon sources glutamate and glucose reduced the cidality
of both 5 and rifampicin. These complex responses did
not allow us to conclusively identify fatty acid oxidation as
a pathway target.
Finally, we generated a knockout of htpG, which encodes a
predicted protein chaperone (Supplementary Figures S5A,B)
and obtained the knockout strain of fecB, a putative iron(III)
dicitrate-binding protein (Xu et al., 2017). The strain deficient
in FecB was slower than WT to recover after 3 days under
NR conditions (Supplementary Figure S5C). Also striking, the
1htpG strain had a fourfold decrease in CARAMBC when exposed
to 1 and 5 (Supplementary Figure S5D) compared to the
wild type. We purified recombinant HtpG and used differential
scanning fluorimetry to determine if 5 binds HtpG. In contrast
to HtpG’s natural ligand, ADP, 5 did not alter the melting
temperature of HtpG (Supplementary Figure S5E). This may
indicate that conditions leading to binding in the intact cell were
not recapitulated in vitro or that, indeed, there is no ligand-
protein interaction.
DISCUSSION
The NR-active cephalosporins studied here were inactive on
isolated Ldts and pulled down no Ldts or PBPs by ABPP.
In contrast, ABPP identified at least 30 other cephalosporin
binding proteins reproducibly and selectively. While one putative
protein partner is predicted to be a metallo-β-lactamase, no
other β-lactam-associated proteins were among the 30 candidate
targets. Enzymes of fatty acid metabolism, universal stress
TABLE 2 | Potential cephalosporin binding proteins from NR cells.
Accession Rv number Gene Essentiality? Description
Fatty acid metabolism
L7N5P2 Rv3224 No PP: oxidoreductase, short-chain dehydrogenase/reductase family
O53442 Rv1094 desA2 Yes PP: putative acyl-[acyl-carrier-protein] desaturase
Q7D7S1 Rv1925 fadD31 No PP: acyl-CoA synthase
Q50824 Rv0685 desA1 Yes PP: putative acyl-[acyl-carrier-protein] desaturase
L7N5S5 Rv0222 echA1 No SF: probable enoyl-CoA hydratase; crotonase
P0A4W6 Rv2244 AcpM Yes SF: meromycolate extension acyl carrier protein
Q11198 Rv3389c htdY No SF: 3-hydroxy acyl thioester dehydratase
Ribosomal/transcriptional function
P66044 Rv0651 rplJ Yes PP: 50S ribosomal protein L10
Q10788 Rv2889c tsf Yes PP/SF: elongation factor Ts
P0A558 Rv0685 tuf Yes PP: elongation factor Tu
P66701 Rv3457c rpoA Yes PP: DNA-directed RNA polymerase subunit alpha
P64887 Rv1738 – No SF: uncharacterized protein Rv1738; potential hibernation factor
Universal stress proteins and chaperones
P0A5F7 Rv1996 Usp No PP: universal stress protein; appears redundant
P64411 Rv2299c htpG No PP: chaperone protein
P64921 Rv2005c Usp No PP: universal stress protein; appears redundant
O06189 Rv2623 Usp No PP: universal stress protein
ATP synthesis
P63671 Rv1309 atpG Yes PP: ATP synthase gamma chain
P63673 Rv1308 atpA Yes PP: ATP synthase subunit alpha
P63677 Rv1310 atpD Yes PP: ATP synthase subunit beta
Intermediary metabolism enzymes
P0A544 Rv2996c serA Yes PP: D-3-phosphoglycerate dehydrogenase
P60176 Rv3248c sahH Yes PP: adenosylhomocysteinase; thioester hydrolase
P64178 Rv1436 gap Yes PP: glyceraldehyde-3-phosphate dehydrogenase
P65149 Rv3001c ilvC Yes PP: ketol-acid reductoisomerase
Q10530 Rv0896 gtlA2 Yes PP: citrate synthase 1
P0A590 Rv2220 glnA1 Yes PP: glutamine synthetase 1
P95143 Rv0694 lldD No PP: putative L-lactate dehydrogenase
P65682 Rv2607 pdxH No SF: pyridoxine/pyridoxamine 5′-phosphate oxidase
Unknown function
O53291 Rv3044 fecB No SF: probable Fe(III)-dicitrate binding lipoprotein
O53672 Rv0250c – No SF: uncharacterized protein
P71839 Rv0786c – No SF: conserved protein
C5 pulldown proteins: PP, precipitate fraction; SF, soluble fraction.
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FIGURE 5 | Characterization of Rv1738 as a potential hibernation factor.
(A) Size exclusion chromatography of purified Rv1738 (red), size standards
(44 and 17 kDa) are in black. (B) Cell-free ribosome activity with increasing
concentrations of Rv1738 incubated with 240 µM of 1, 5, C5, or 9c.
Luminescence (RLU) from the activity of the luciferase protein translated from
the nano-luciferase mRNA, served as a surrogate measure of ribosomal
activity.
proteins, and ribosome-associated proteins stood out as clusters,
and several other enzymatic pathways were represented.
The isolation of seemingly unrelated chemical classes is
not uncommon in the ABPP approach. A chemical proteomic
strategy was used to isolate the targets of 10 alkyne β-lactone
analogs in the proteomes of several Gram-negative and Gram-
positive bacteria (Bottcher and Sieber, 2008), leading to isolation
of acetyl-CoA hydrolases, several β-ketoacyl carrier protein
synthases, ligases, and oxidoreductases, among other enzymes.
Another study used several alkyne β-lactam probes including two
penems containing an alkyne moiety either at the amino group
(AmpN) or the carboxyl group (AmpC) and one cephalosporin
with the alkyne at the amino group (CephN) (Staub and Sieber,
2008). Using Pseudomonas putida and two Gram-positive soil
bacteria (Listeria welshimeri and Bacillus licheniformis) for their
ABPP experiments, Staub and Sieber obtained similar results
to ours in that AmpC, unlike AmpN, more readily bound
non-PBPs. Even though the CephN contained a free carboxylic
acid, in B. licheniformis, it bound a non-PBP protein called
DltD, a membrane-bound thioesterase involved in lipoteichoic
acid synthesis (Debabov et al., 2000; Staub and Sieber, 2008).
Along with the high-molecular-weight and low-molecular-
weight members of the PBP superfamily, Staub and Sieber also
isolated β-ketoacyl-acyl carrier protein synthase III from multiple
species with alkyne β-lactam probes. Thus, ABPP with β-lactam
probes can identify non-canonical targets.
Several potential protein binders of 1 and 5 have roles
in the Mtb stress response. Mutations in fecB rendered Mtb
hypersusceptible to diverse classes of antibiotics, including
vancomycin, isoniazid, ethambutol, and meropenem (Xu et al.,
2017). Despite its annotation as an iron (III) dicitrate-
binding periplasmic lipoprotein, knockout of fecB did not alter
the mutant’s ability to grow in iron-limiting or iron-replete
conditions; however, the 1fecB mutant was more permeable
to ethidium bromide and fluorescently tagged vancomycin (Xu
et al., 2017). The fecB mutant’s weakened cell wall barrier could
explain the increase in susceptibility to a wide range of antibiotics
and perhaps also to nitroxidative stress. HtpG, the bacterial
homolog of the eukaryotic chaperone Hsp90, has an important
role in the adaptation of E. coli to environmental stresses,
including incubation at high temperature (Grudniak et al., 2013)
and host cell infection (Garcie et al., 2016); however, in Mtb,
much remains to be learned about the nature and function of
this chaperone (Lupoli et al., 2018). Using DSF, we did not detect
interaction of compounds 1 and 5 with HtpG. In intact cells, the
disruption in proteostasis caused by the loss of htpG, along with
additional stresses after addition of β-lactam and nitric oxide,
might lead to the increased sensitivity seen in the htpG knockout
versus wild-type Mtb in the presence of compound.
Rv1738, encoding a 94-amino-acid protein considered non-
essential for growth (DeJesus et al., 2017), is the most abundantly
upregulated gene under hypoxic conditions (Sherman et al.,
2001). Rv1738 is also upregulated during NO stress (Voskuil
et al., 2003). The crystal structure indicates that the dimer bears
a close structural similarity to theβαβββα motif of hibernation
promoting factor (Bunker et al., 2015). Purified Rv1738 appeared
dimeric when eluted from a size exclusion column. When
bacteria approach a dormant state, protein synthesis is retarded
by the inactivation of their ribosomes. Ribosome modulation
factor and hibernation factor promote and stabilize dimerization
of the ribosomal subunits. The binding of these small proteins
to the head domain of the 30S ribosomal subunit impedes
the interaction of tRNAs and mRNAs with the 16S ribosomal
RNA and induces a conformational change of the 30S subunit
(Polikanov et al., 2012). Cryo-EM structures of ribosomes
isolated from stationary phase Mycobacterium smegmatis showed
100S dimers but did show 70S ribosomes bound to a hibernation
factor at the t-RNA binding site (Mishra et al., 2018). Our findings
indicate that Rv1738 can behave like a hibernation promoting
factor in vitro but how it does so remains to be determined. We
did not find evidence that NR-active cephalosporins inhibit the
action of Rv1738 in vitro, but we cannot exclude that they might
do so in the intact cell.
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FIGURE 6 | Effects of fatty acid carbon sources on the activity of NR-active cephalosporins under NR conditions. (A) NR activity of 5 against transposon mutants in
genes encoding enzymes involved in fatty acid metabolism. (B) NR activity of 5 using 0.05% acetate, 0.05% propionate, 0.05% butyrate, 0.015% hexanoate,
0.00025% palmitate, 0.2% glucose, or 0.2% glutamate as the sole carbon source in NR media. (C) When exposed to a concentration of compound equivalent to its
CARAMBC, reduction in viability after 7 days of treatment using various carbon sources in the NR media.
A meta-analysis of the M. tuberculosis transcriptomic
landscape revealed that several genes encoding candidate binding
proteins, including rv2005c, rv199c, and rv2623 are upregulated
when the bacilli are under stress conditions. Rv2005c encodes
a universal stress protein and is upregulated under hypoxic
conditions (Parvati Sai Arun et al., 2018). Rv2005c and Rv1996c
belong to the same family of proteins as Rv2623, another
universal stress protein. Rv2623 is upregulated during NO
exposure or hypoxic stress (Glass et al., 2017). Rv2623 has
a role in the establishment of chronic infection in mice and
overexpression slowed the growth of the cells (Drumm et al.,
2009). However, the transposon mutants of rv2623, rv1996, or
rv2005 had no discernable phenotype in our NR 4-stress model.
This does not exclude their possible collective relevance, given
that the biological roles of Rv2005c and Rv1996c appear to be
functionally redundant (Hingley-Wilson et al., 2010).
There is likely redundancy among the binding partners
involved in fatty acid metabolism. Exposure to NO reportedly
increased the expression of AcpM and other enzymes involved
in fatty acid biosynthesis, and β-oxidation enzymes were induced
by host intracellular environments (Parvati Sai Arun et al., 2018).
This is consistent with the importance of host-derived fatty
acids as carbon sources for Mtb during infection (McKinney
et al., 2000; Schnappinger et al., 2003). Several studies have
highlighted a link between central-carbon metabolism and
antibiotic susceptibility and tolerance (Hicks et al., 2018; Lee
et al., 2019) in which the bacterium altered its carbon flux to
increase its survival during antibiotic stress. Because carbon
metabolism in Mtb is distinctive and the metabolic fate of
different carbon sources can differ (de Carvalho et al., 2010),
further studies are needed to understand how these non-
traditional cephalosporins affect the compartmentalization of
Frontiers in Microbiology | www.frontiersin.org 9 June 2020 | Volume 11 | Article 1248
fmicb-11-01248 June 19, 2020 Time: 17:53 # 10
Lopez Quezada et al. Non-classical Cephalosporin Targets in Mtb
these carbon sources, particularly fatty acids. At an individual
level, the functional loss of fadD31 and echA1 did not appear
to affect the efficacy of 5 or 1 (data not shown), but there
appears to be redundancy among genes in these classes (Williams
et al., 2011); indeed, Mtb has over 100 genes annotated to
be involved in the five reactions that convert fatty acids
into acetyl-CoA.
In sum, the isolation of several protein families that are
important in Mtb stress responses or adaptation to the host
environment and that have mutually redundant members
suggests that cephalosporins 1 and 5 may kill NR Mtb through
collective inhibition of more than one target. However, it remains
possible that there is a single, functionally relevant target we did
not identify by ABPP due its low abundance or tight association
with insoluble components, and it remains possible that the high
abundance of several of the protein binders could explain their
presence as pulldown clients. Moreover, one or more of the
binding proteins that are essential under replicating conditions
could represent the functionally relevant target or targets under
NR conditions if the NR-active cephalosporins inhibit such
target(s) partially and NR conditions disable the same target(s)
as well, the combined effect being necessary to kill Mtb.
MATERIALS AND METHODS
Materials
Compounds 1, 5, and 9c were synthesized as described below.
The biotin-diol-azide linker was obtained from Click Chemistry
Tools (Scottsdale, United States). Activated charcoal, sodium
resazurin, sodium periodate, Triton X-114, isoniazid, rifampicin
(Rif), and dimethyl sulfoxide (DMSO) were from Sigma-
Aldrich, United States. The tris-(2-carboxyethyl)phosphine HCl
(TCEP) and streptavidin-agarose beads used for enrichment and
purification were from Thermo Fisher Scientific, United States.
Synthesis of Alkyne Probes
All starting β-lactams were prepared as described




To a solution of (6R,7R)-7-(2-(4-methoxyphenoxy)acetamido)-
3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-
carboxylic acid (2.33 g, 6.17 mmol) in methyl isobutyl ketone
(195 ml), a solution of potassium 2-ethylhexanoate hydrate
(1.69 g, 9.25 mmol) in 1-butanol (37.5 ml) was added. The
reaction became clouded. Hexanes were added until an off-white
solid crashed out of solution. The precipitate (2.57 g, 6.17 mmol)
was collected via filtration and used without further purification.
To a suspension of this precipitate (2.57 g, 6.17 mmol) in DMF
(30.9 ml, 0.20 M), 3-iodoprop-1-yne (4.79 ml, 30.9 mmol)
was added. The mixture was allowed to stir at RT for 16 h.
Solvent was removed and the residue was purified via silica
gel MPLC to give C1a (1.78 g, 69%) as a white solid. Purity:
92%. 1H NMR (400 MHz, DMSO-d6) δ 9.00 (d, J = 8.3 Hz,
1H), 6.90–6.81 (m, 4H), 5.67 (dd, J = 8.3, 4.7 Hz, 1H), 5.12
(d, J = 4.7 Hz, 1H), 4.94–4.77 (m, 2H), 4.60–4.49 (m, 2H), 3.69
(s, 3H), 3.63–3.55 (m, 2H), 3.32 (s, 1H), 2.05 (s, 3H). 13C NMR
(101 MHz, DMSO-d6) δ 168.7, 164.2, 161.3, 153.8, 151.8, 133.4,
121.3, 115.5, 114.5, 78.1, 77.9, 66.9, 58.8, 57.3, 55.4, 52.6, 29.2,
19.4. HR-MS (ESI): calculated for C20H21N2O6S [M + H]+
417.1115; found, 417.1088.
Pent-4-ynoyl chloride
To a solution of pent-4-ynoic acid (1.55 g, 15 mmol) in DCM
(15 ml) was added three drops of DMF at 0◦C, followed by slow
addition of oxalyl chloride (3.86 ml, 45 mmol). The reaction
mixture was stirred at RT for 2 h, and then the solvent was
removed under reduced pressure to afford the product (1.66 g,
95%) as an oil and used without purification.
(6R,7R)-3-Methyl-8-oxo-7-(pent-4-ynamido)-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
To a suspension of 7-ADCA (3.21 g, 15.0 mmol) in water
(100 ml), NaHCO3 (1.26 g, 15.0 mmol) and acetone (12.0 ml)
were added, followed by the addition of pent-4-ynoyl chloride
(1.75 g, 15.0 mmol). The reaction was stirred at RT for
16 h. DCM (100 ml) was added and the reaction mixture
was acidified using 6N HCl to pH 2. The organic layer was
removed and the aqueous portion was extracted again with
DCM (100 ml). The organic extracts were combined, washed
with brine, and dried over MgSO4. Solvent was removed
after filtration and the solid was suspended in ether and
stirred for 8 h. The product was isolated through vacuum





0.13 g, 64% yield. Purity: 92%. A similar procedure to C1a
was used for the synthesis with corresponding acid and 1-
iodopopane. 1H NMR (400 MHz, CDCl3) δ 6.74 (d, J = 8.8 Hz,
1H), 5.79 (dd, J = 8.8, 4.7 Hz, 1H), 4.96 (d, J = 4.7 Hz, 1H), 4.27–
4.09 (m, 2H), 3.49 (d, J = 18.3 Hz, 1H), 3.21 (d, J = 18.3 Hz,
1H), 2.57–2.46 (m, 4H), 2.13 (d, J = 0.9 Hz, 3H), 2.04–2.00
(m, 1H), 1.75–1.66 (m, 2H), 0.96 (t, J = 7.4 Hz, 3H). 13C
NMR (101 MHz, CDCl3) δ 171.4, 164.5, 162.2, 131.2, 122.7,
82.5, 69.6, 67.3, 58.9, 57.1, 34.8, 30.2, 21.8, 20.0, 14.6, 10.4. HR-
MS (ESI): calculated for C16H21N2O4S [M + H]+ 337.1217;
found, 337.1228.
N-Hydroxypent-4-ynimidamide
To a solution of hydroxylamine hydrochloride (1.05 g,
15.0 mmol) in water (5 ml), sodium hydroxide (0.60 g,
15.0 mmol) was added. The resulting solution was added to pent-
4-ynenitrile (1.19 g, 15.0 mmol) in about 2 min. The mixture was
stirred at RT for 2 days. Solvent was removed and residue was
treated with EtOH and the resulting suspension was filtered. The
filtrate was concentrated in vacuo to afford product (0.84 g, 50%)
as a white solid, which was used without further purification.
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To a solution of 2,4-dinitrophenol (0.92 g, 5.00 mmol) in DCM
(20 ml), (6R,7R)-3-methyl-8-oxo-7-(2-phenylacetamido)-5-thia-
1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid in a minimal
amount of 1,4-dioxane was added, followed by the addition of
1,3-diphenylcarbodiimide (0.97 g, 5.00 mmol) in DCM (10 ml).
The mixture was stirred at RT for 30 min. After the filtration,
N-hydroxypent-4-ynimidamide was added to the filtrate and
the mixture was stirred at RT overnight. The mixture was then
washed twice with sat. aq. NaHCO3, filtered, and concentrated
in vacuum to afford the residue, which was purified via silica gel
MPLC (100% EtOAc) to give the intermediate (0.18 g) as a white
solid, which was heated at 120◦C in a vacuum oven overnight.
Purification via silica gel MPLC afforded the desired product
(68 mg, 39%, two steps) as a white solid. Purity: 98%. 1H NMR
(400 MHz, DMSO-d6) δ 9.12 (d, J = 8.2 Hz, 1H), 7.33–7.19 (m,
5H), 5.72 (dd, J = 8.2, 4.7 Hz, 1H), 5.20 (d, J = 4.7 Hz, 1H), 3.75–
3.47 (m, 4H), 2.97 (t, J = 7.1 Hz, 2H), 2.82 (t, J = 2.7 Hz, 1H),
2.63 (td, J = 7.2, 2.7 Hz, 2H), 2.15 (s, 3H). 13C NMR (101 MHz,
DMSO-d6) δ 171.0, 170.2, 169.1, 165.2, 135.8, 132.7, 129.0, 128.2,
126.5, 115.7, 82.5, 72.2, 59.2, 57.6, 41.6, 29.0, 24.9, 19.8, 15.7.





A similar procedure to that described for C5 was used starting
with (6R,7R)-3-methyl-8-oxo-7-(pent-4-ynamido)-5-thia-1-
azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid and acetonitrile.
Obtained 0.137 g (15% yield for the last two steps). Purity: 100%.
1H NMR (400 MHz, CDCl3) δ 6.62 (d, J = 8.6 Hz, 1H), 5.86 (dd,
J = 8.6, 4.7 Hz, 1H), 5.08 (d, J = 4.7 Hz, 1H), 3.58 (d, J = 18.4 Hz,
1H), 3.33 (d, J = 18.4 Hz, 1H), 2.58–2.46 (m, 4H), 2.45 (s, 3H),
2.22 (s, 3H), 2.02 (t, J = 1.7 Hz, 1H). 13C NMR (101 MHz,
DMSO-d6) δ 171.4, 170.2, 167.3, 165.3, 132.4, 115.5, 83.5, 71.5,
59.1, 57.5, 33.7, 29.0, 19.8, 14.1, 11.4. HR-MS (ESI): calculated for
C15H17N4O3S [M+H]+ 333.1021; found, 333.0981.
Bacterial Strains and Growth Conditions
Actively growing WT Mycobacterium tuberculosis strain H37Rv
(Mtb, ATCC 25618) was grown in Middlebrook 7H9 broth
supplemented with 10% oleic acid, dextrose and catalase (OADC)
(BD Difco, United States), 0.5% glycerol, and 0.02% Tyloxapol
(Sigma) and incubated at 5% CO2 and 20% O2 at 37◦C. H37Rv
transposon mutants of Mtb rv1925, lldD, rv3389, rv1996, rv2005,
rv0786, rv3224, pdxH, fadD31, rv2623, and rv0222 H37Rv [a
generous gift from Deborah Hung (Barczak et al., 2017)] were
grown in Middlebrook 7H9 containing 25 µg/ml kanamycin.
Non-replicating assays were done using a reported 4-stress model
(Warrier et al., 2015; Gold et al., 2016b). In brief, replicating
cells were washed twice and diluted to an OD580 of 0.1 in
non-replicating (NR) medium: modified Sauton’s base (0.05%
KH2PO4, 0.05% MgSO4, and 0.005% ferric ammonium citrate
at pH 5.0) with 0.02% tyloxapol, 0.5% bovine serum albumin
(BSA), 0.0001% ZnSO4, and 0.05% (NH4)2SO4 0.085% NaCl;
butyrate (0.05%) was used as the carbon source and a flux
of nitric oxide was generated by adding 0.5 mM NaNO2 to
the acidified medium. For conditions involving different carbon
sources, the butyrate was replaced with 0.05% acetate, 0.05%
propionate, 0.015% hexanoate, 0.00025% palmitate, 0.2% glucose,
or 0.2% glutamate, and the pH was adjusted to 5.0. The cells
were incubated with 5% CO2 and 1.0% O2 at 37◦C. Unless
otherwise stated, cells were exposed to compounds for 7 days
for the following assays: minimum inhibitory concentration
(MIC), charcoal agar resazurin assay (CARA), or colony-
forming unit (CFU).
Compound Activity (CFU/ml, MIC, and
CARA)
Bacilli were enumerated by plating serially diluted bacterial
cultures on 7H11 agar (BD Difco, Franklin Lakes, NJ,
United States) plates supplemented with 0.5% glycerol and 10%
OADC. MICs were determined by serially diluting compounds
in DMSO and dispensing into 96-well plate with 200 µl of cells.
The final DMSO concentrations did not exceed 1%. Compound
dilutions were prepared the same day of experiments. For the
replicating MIC assays, bacterial suspensions were diluted to
an OD580 of 0.01 and added to the 96-well plate containing
the compound. The MIC of a compound was the lowest
concentration leading to ≥90% inhibition of the cell growth
compared to cells treated with vehicle (DMSO). Growth was
determined by OD580. For non-replicating cells, the NR MIC was
determined as described (Warrier et al., 2015) by resuspending
cells from the NR plates and using 1/20 of the volume to inoculate
a second plate containing replication-supporting, supplemented
7H9 broth. The latter plates were incubated under replicating
conditions for 10–12 days before recording the OD580. CARA
plates were prepared and assayed as described (Gold et al., 2015a,
2016a). In brief, after 7 days of compound exposure, cells in the
assay plate were resuspended and 10 µl were used to inoculate
CARA plates containing agar with 4 g/L activated charcoal. After
incubating the CARA plates for 7 days (replicating assay) or 12–
14 days (NR assay), growth was estimated by adding 50 µl of
0.01% resazurin in PBS with 0.02% Tyl to each well of the CARA
plates. The CARAMBC was defined as the lowest concentration of
compound that reduced fluorescence to ≤1% of that in DMSO
control wells for each strain, which corresponds to a difference in
viable cell number of ≥2–3 log10 CFU (Gold et al., 2016a).
Ldts and BlaC Kinetics
Production, purification, and activity of Mtb LdtMt1 and LdtMt2
and E. faecium Ldtfm were carried out as previously described
(Cordillot et al., 2013; Edoo et al., 2017). Briefly, BlaC hydrolysis
of 1, 5, and 9c was determined by incubating 100 µM of each
compound with 50 and 500 nM of the enzyme in 100 mM
MES buffer at pH 6.4. Inhibition of BlaC-mediated hydrolysis
of nitrocefin was tested by incubating 2 nM of BlaC in the
presence of increasing concentration of 1, 5, and 9c and 50 µM
of nitrocefin. To account for time-dependent inhibition, 1 nM
of BlaC was incubated for 2 h with the compounds prior to the
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addition of nitrocefin. In the case of LdtMt1 and LdtMt2, all kinetic
tests were conducted in 100 mM sodium phosphate at pH 6.0 at
20◦C. To asses Ldt hydrolysis of the compounds, 50 µM of 1,
5, or 9c was incubated with increasing concentration of Ldt (0,
1, 5, and 10 µM). Inhibition of enzyme activity was determined
by incubating 5 µM of the Ldt enzymes in the presence of test
compounds (0, 25, 50, and 100 µM) and 50 µM of nitrocefin.
Assays were performed using enzymes incubated for 30 min
with the compounds prior to the addition of nitrocefin. Stopped
flow kinetics were conducted using Ldtfm in 100 mM sodium
phosphate at pH 6.0 at 10◦C. Ldtfm (15 µM) and 20 µM of 1,
5, or imipenem were mixed, and the acylated form of Ldtfm was
monitored by mass spectrometry.
Bacterial Proteome Ligand Binding
Mtb cells were washed with PBS containing 0.02% Tyloxapol,
diluted to an OD580 of 0.8–1.0 in 30-ml cultures, and pre-
adapted to non-replicating conditions for 24 h. Following the
pre-adaptation to NR conditions, 50–70 µM of compounds or
vehicle control (DMSO) was added to the cultures and placed
back in the 37◦C incubator. After a 24-h exposure to compounds,
cells were washed 2× with PBS containing 0.02% Tyloxapol,
harvested, and stored at−80◦C until ready for lysis. The protocol
as shown in Figure 3 was conducted twice.
Extraction buffers consisted of PBS containing Roche Protease
Inhibitor Cocktail and 2% Triton X-114 in PBS (kept at 4◦C)
as previously described (Malen et al., 2010) with modifications.
Samples were resuspended in ∼720 µl of PBS and transferred
to bead beating tubes containing 500 µl of zirconium beads.
Samples were maintained ice cold. Bacteria were lysed by bead
beating and centrifuged for 5 min at 1400 × g to remove beads
and unlysed cells. There was approximately 800 µl of lysate.
Eighty microliters of PBS-20% Triton X-114 solution was added
to each sample. Samples rotated gently at 4◦C overnight. To
remove insoluble material, samples were centrifuged at 4◦C at
8600 × g for 10 min. In contrast to published protocols, samples
were maintained chilled such that the detergent (membrane)
fraction and aqueous phase were maintained in solution. In our
experience, phase separation reduced the final yield of proteins.
Probe Conjugation, Purification and
Enrichment of Target Proteins
Based on published general click chemistry protocols (Speers
and Cravatt, 2009; Yang et al., 2013), samples were diluted
with PBS to halve the detergent concentration (<1%) prior to
incubating them overnight at 4◦C with streptavidin beads. Once
biotinylated proteins were removed, protein concentrations were
determined using the Pierce BCA Protein Assay Kit (Thermo
Fisher Scientific, United States) and samples were diluted to
the same protein concentration (∼1 mg/ml). The samples were
divided into 500-µl aliquots. For Cu(I) catalyzed Huisgen’s azide
alkyne cycloaddition reactions, the following was added to each
sample: 5.0 µl of 5 mM diol-biotin-azide (50 µM final), 11.3 µl
50 mM TCEP (1 mM final), 7.0 µl 1.7 mM TBTA (tris[(1-
benzyl-1H-1,2,3-triazol-4-yl)methyl]amine) (50 µM final), and
11.3 µl of 50 mM CuSO4 (1 mM final). Samples were vortexed
between each step and kept in the dark. The reaction proceeded
for 1 h at RT with vortexing after 30 min of incubation. Some
proteins precipitated out of solution. Accordingly, samples were
centrifuged for 15 min at 10,000 × g and the pellet was set
aside as the “precipitate.” The pellet was washed with 500 µl
of cold methanol and resuspended in 2.5% SDS to solubilize
the proteins. The precipitate fractions were diluted to <0.2%
SDS prior to the addition of the streptavidin beads. To stop the
reaction in the supernatant or “soluble fraction” and remove
excess reagents, samples were run through a PD-10 column
(Bio-Rad). One hundred microliters of streptavidin-agarose bead
slurry was added to each sample and incubated overnight at 4◦C.
The beads were washed 2× with 1 volume of PBS containing
0.1% Triton X-100 including one O/N wash. This was followed
by three washes with PBS. Proteins were eluted from the beads
by resuspending the slurry in 10 mM sodium periodate in
100 mM sodium phosphate buffer, pH 7.4. The samples were
incubated for 30 min in the dark with rotation. Glucose (20 mM
final) was added to quench the reactions. Samples were desalted
using Zeba spin columns (Thermo Fisher Scientific). Samples
were concentrated by TCA precipitation and analyzed by silver
staining, Western blot, and mass spectrometry.
Rv1738 Purification and Ribosomal
Inhibition
Rv1738 and ribosome functional assays were performed
as previously described (Li et al., 2015) in which Rv1738
was cloned into p1602-dest (Life Technologies) with a
C-terminal His6x tag on Rv1738. Rv1738 was purified with
Ni2+ chromatography column (GE Healthcare), followed by
size exclusion chromatography. A superdex 75 column (GE
Healthcare) was used for size exclusion chromatography in
a buffer containing 20 mM Tris–Cl (pH 7.5) and 150 mM
NaCl, and the protein profile was compared with protein
molecular size standards.
In order to purify Mtb ribosome, Mtb strain MC27000
was grown in 7H9 medium supplemented with 10% OADC
supplement (BD), 0.5% glycerol, 0.05% Tween-80, and 50 µg/ml
pantothenic acid at 37◦C until an OD600 of 1.0. Harvested cells
were lysed in a bead beater (BioSpec) in lysis buffer [20 mM Tris–
HCl (pH 7.5), 100 mM NH4Cl, 10 mM MgCl2, 0.5 mM EDTA,
and 6 mM 2-mercaptoethanol]. The cell lysate was clarified by
centrifugation at 30,000× g for 1 h. The supernatant was pelleted
in a sucrose cushion buffer [20 mM HEPES (pH 7.5), 1.1 M
sucrose, 10 mM MgCl2, 0.5 M KCl, and 0.5 mM EDTA] at
40,000 rpm in a Beckman Type 45Ti rotor for 20 h. The pellet
was resuspended in a buffer of 20 mM Tris–HCl (pH 7.5), 1.5 M
(NH4)2SO4, 0.4 M KCl, and 10 mM MgCl2. The suspension was
then applied to a hydrophobic interaction column (Toyopearl
Butyl-650S) and eluted with a reverse ionic strength gradient
from 1.5 to 0 M (NH4)2SO4 in a buffer containing 20 mM Tris–
HCl (pH 7.5), 0.4 M KCl, and 10 mM MgCl2. The eluted ribosome
peak was changed to re-association buffer [5 mM HEPES-NaOH
(pH 7.5), 10 mM NH4Cl, 50 mM KCl, 10 mM MgCl2, and 6 mM
2-mercaptoethanol] and concentrated before loading on top of
a 10–40% linear sucrose gradient and centrifuged in a Beckman
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SW28 rotor at 19,000 rpm for 19 h. The 70S fractions were
concentrated to about A260 = 300 after removal of the sucrose.
Mtb S30 cell-free extract was prepared according to methods
(Swartz et al., 2004) and S100 extract was prepared by removing
endogenous ribosomes from the S30 extract. The 15 µl of the
S100 extract that includes translation factors such as initiation,
elongation, termination, recycling factors, and aminoacyl tRNA
synthetase was mixed with 5 µl 10 × salt buffer (2 M potassium
glutamate, 0.8 M ammonium acetate, and 0.16 M magnesium
acetate), 1 mM each of the 20 amino acids, 33 mM PEP, and 2%
poly(ethylene glycol) 8000. Rv1738 or the compounds or their
mixtures with ribosomes were added to the reactions prior to
the master mix and mRNA. The reaction was started by the
addition of nano-luciferase mRNA (200 ng in 2 µl) and 5 µl
of 5× master mix (286 mM HEPES-KOH, pH 7.5, 6 mM ATP,
4.3 mM GTP, 333 µM folinic acid, and 853 µg/ml tRNA) to reach
a final volume of 50 µl. The reaction was allowed to proceed
for 40 min at 37◦C and the luminescent signal was detected by
the addition of 20 µl of the nano-luciferase substrate furimazine.
1, 5, 9c, and C5 were first tested in the cell-free translation
assay to ensure that the compounds alone did not inhibit
ribosomal activity. To test the impact that the compounds had
on Rv1738-mediated inhibition of translation, we tested several
combinations: ribosomes and 10 µM Rv1738 were incubated for
10 min followed by the addition of 240 µM of the compounds;
ribosomes and 240 µM compounds were incubated for 10 min
followed by the addition of 10 µM of Rv1738; 10 µM of Rv1738
was incubated with 240 µM compounds before mixing with
ribosomes; and finally, the reaction was carried out in which
240 µM compounds and ribosome were co-incubated first,
followed by the titration of Rv1738.
HtpG Characterization and Differential
Scanning Fluorimetry (DSF)
Mycobacterium tuberculosis1htpG was generated using a suicide
plasmid approach, which enlists Gateway cloning techniques
and vectors. Briefly, ∼1100 bp fragments, including regions
upstream and downstream of htpG (rv2299c), were amplified
from chromosomal M. tuberculosis H37RvN DNA using primers
1–4 (Supplementary Table S3). The fragments were cloned
into pDE43-XSTS (a temperature-sensitive plasmid) containing
a zeocin resistance cassette, which was amplified from pGMCZ-
PrpoB using primers 9 and 10 to produce pKO-XSTS-htpG-tb
(Pelicic et al., 1997; Kim et al., 2011; Ganapathy et al., 2015).
M. tuberculosis H37RvN was transformed with pKO-XSTS-htpG-
tb and plated on 7H10 agar containing zeocin (50 µg/ml),
followed by incubation at the permissive temperature of 37◦C.
Resulting transformants were then inoculated into 7H9 complete
(with Tween-80) containing zeocin (25 µg/ml) at 37◦C and
grown to stationary phase. Cells were periodically plated on
7H10 agar with zeocin (50 µg/ml) containing 10% sucrose and
incubated at the restrictive temperature of 40◦C. Pyrocatechol
(0.5 M) was added to plates that contained colonies and white
colonies were inoculated into 7H9 complete (with Tween-80)
containing zeocin (25 µg/ml) and grown at 37◦C prior to
purification of DNA and confirmation of allelic exchange by
Southern blot. Southern blot of selected clones was performed
using a DNA probe (∼400 bp) generated with primers 5–6
(Supplementary Table S3) in order to analyze genomic DNA
from M. tuberculosis wild type and candidate 1htpG clones
digested with PvuII (Supplementary Figure S5). Deletion of
htpG and insertion of zeocin resistant cassette were confirmed
by whole genome sequencing. For overexpression of HtpG in
Mtb 1htpG, we generated pMCH_pH60_SD_htpG using primers
11 and 12 (Supplementary Table S3), an episomal vector that
expresses htpG under the control of the hsp60 promoter, as has
been previously described (Kim et al., 2011; White et al., 2018).
Recombinant M. tuberculosis HtpG was cloned and purified
using previously described methods (Lupoli et al., 2016). The
overexpression plasmid was constructed by overlap extension
PCR cloning techniques (Bryksin and Matsumura, 2010) with
pET-His-SUMO plasmid (Addgene #29711) and primer pair
7–8 (Supplementary Table S3). DNA samples were purified
using a PCR purification kit (Qiagen) and transformed into
Mach1 competent cells (Invitrogen). After confirmation of
gene insertion by DNA sequencing, the selected plasmid
was transformed into Rosetta2 competent cells (Novagen) for
overexpression and purification using similar techniques to those
previously described for other mycobacterial chaperones (Lupoli
et al., 2016). For expression, E. coli Rosetta2 cultures containing
His6-SUMO-HtpG overexpression plasmid were grown in LB
medium supplemented with 50 µg/ml carbenicillin, 30 µg/ml
chloramphenicol, and 0.1% glucose, and then used to inoculate
0.5 L of LB medium (1:100) supplemented with 50 µg/ml
carbenicillin and 30 µg/ml chloramphenicol at 37◦C and grown
to OD600 = 0.3–0.4 with shaking. Cells were cooled to 16◦C
and grown to OD600 ∼ 0.5 before induction with 0.01 mM
isopropyl-β-D-thiogalactoside (IPTG) for 18 h with shaking.
Cells were harvested by centrifugation (3100 × g, 10 min,
4◦C) and pellet was resuspended on ice with 15 ml of Buffer
A [25 mM tris(hydroxymethyl)aminomethane (Tris) (pH 8.0),
400 mM NaCl, 10% glycerol] containing 100 µg/ml lysozyme
and 3 µg/ml DNaseI. The suspension was rocked for 30 min
at 4◦C prior to lysis by sonication on ice using a 30-s interval
program at an amplitude of 5 for a total of 5 min. Samples
were then ultracentrifuged at 39,191 × g for 30 min at 4◦C.
The resulting supernatant was added to 1.5 ml of washed Ni-
NTA agarose resin (Qiagen) with 2 mM added imidazole and
rocked at 4◦C for 30 min. The resin was then washed with
30 ml of wash buffer (30 mM imidazole in Buffer A) and His6-
SUMO-HtpG was eluted with 10 ml of elution buffer (200 mM
imidazole in Buffer A). The eluate fractions were dialyzed against
2 L of Buffer A overnight using a 10-kDa MWCO Slide-A-Lyzer
dialysis cassette (Pierce). His6-SUMO protease (0.04 mg/ml; His-
Ulp1, purified from Addgene #31122) was added to the dialysis
sample to cleave the His6-SUMO tag from each protein as has
been previously described (Uehara et al., 2010). To separate His-
tagged and non-tagged proteins, the dialysis samples were then
incubated with 1.5 ml of washed Ni-NTA resin for 1 h at 4◦C. The
flow-through and 3 ml of Buffer A were passed over the column,
collected, and contained the desired untagged protein without
non-native residues. The protein sample was concentrated to
<1 ml using a 30-kDa MWCO Amicon Ultra Centrifugal Filter
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Device (Millipore) at 4◦C followed by flash freezing with N2(l)
and storage at−80◦C.
Differential scanning fluorimetry was carried out as previously
described (Niesen et al., 2007). Briefly, assays were conducted in
25 mM Tris at pH 8.0, 400 mM NaCl, and 5% glycerol. After
selecting the optimal protein concentration to be used, HtpG was
mixed with test compounds and Sypro dye. The binding of the
Sypro dye to HtpG as the temperature increased (25–90◦C) was
monitored using the Bio-Rad CFX qRT-PCR detection system
and melting curves were derived using the CFX Maestro Analysis
Software (Bio-Rad Laboratories, United States).
Statistical Analysis
Comparisons were analyzed by a two-tailed Student’s t-test with
GraphPad Prism 8. Values of p< 0.05 were considered significant.
CARA assays and CFU data were presented as means± standard
deviation. Unless otherwise specified, experiments were carried
out in triplicate.
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